Residual DNA Quantification Kit-Pig

The past few decades have seen significant advances in the biotechnology and pharmaceutical fields, resulting in the creation of many new therapeutic products and biologics. Among these biologics, genetically engineered products such as recombinant proteins and monoclonal antibodies are particularly important. However, a key concern when producing these biologics is the residual DNA from the host organism, which can pose safety risks such as immunogenic responses or insertional mutagenesis. This requires rigorous monitoring and quantification of residual DNA in the final product to meet regulatory standards and ensure patient safety.

Porcine cells are frequently used in a variety of biopharmaceutical applications due to their physiological similarity to human cells and their suitability for the production of certain therapeutic products. These applications include the production of enzymes, vaccines, and recombinant proteins. However, despite the extensive purification process, trace amounts of porcine DNA can remain in the final product. The Residual DNA Quantification Kit - Porcine is designed to detect and measure the amount of residual porcine DNA in biopharmaceutical products. The need for this specialized kit stems from the use of porcine-derived cells or materials in the manufacturing field, where it is critical to ensure that the residual porcine DNA is within acceptable limits.